At Smart & Biggar, we are experts in Canadian intellectual property (IP) law and policy and understand the role that IP protection plays for innovative companies in the life sciences, driving value and funding the discovery of new life-saving and life-changing drugs.
The life sciences industry has seen radical change over the last two decades and we have kept abreast of these changes, developing an experienced team of practitioners that work with our clients to provide patients with access to their cutting edge technologies.
Our global client base includes ground-breaking start-ups as well as some of the largest life sciences companies in the world. We work with pharmaceutical and biotech companies, medical device companies, well-known research institutions and universities, health services organizations, and venture capital firms.
Our team of legal experts and patent agents work closely with clients to understand their commercial goals and provide a sophisticated approach to managing exclusivity and developing a life-cycle plan that takes into account the complex and evolving legal landscape for drugs, biologics, medical devices and other advanced therapies. We also collaborate with experts in life sciences IP in the US and around the world to coordinate and optimize global obtain protection for Canadian inventions abroad, as well as protection for foreign inventions in Canada. As a result, while our offices are in Canada, our practice and experience covers the globe.